Home/Filings/4/0001209191-23-026754
4//SEC Filing

Daniel William F 4

Accession 0001209191-23-026754

CIK 0001492426other

Filed

May 1, 8:00 PM ET

Accepted

May 2, 7:24 PM ET

Size

9.5 KB

Accession

0001209191-23-026754

Insider Transaction Report

Form 4
Period: 2023-04-28
Transactions
  • Exercise/Conversion

    Ordinary Shares

    2023-04-28+3,91333,794 total
  • Tax Payment

    Ordinary Shares

    2023-04-28$111.16/sh1,879$208,87031,915 total
  • Exercise/Conversion

    Restricted Stock Units

    2023-04-283,9130 total
    From: 2023-04-28Exp: 2023-04-28Ordinary Shares (3,913 underlying)
Holdings
  • Ordinary Shares

    (indirect: By Trust)
    47,670
Footnotes (2)
  • [F1]Each restricted stock unit represents a contingent right to receive one ordinary share of the Issuer.
  • [F2]29,881 Ordinary Shares previously reported as held by Trust held directly.

Issuer

Horizon Therapeutics Public Ltd Co

CIK 0001492426

Entity typeother

Related Parties

1
  • filerCIK 0001529409

Filing Metadata

Form type
4
Filed
May 1, 8:00 PM ET
Accepted
May 2, 7:24 PM ET
Size
9.5 KB